Invest in Holland | June 4, 2019: Rakuten Medical, a clinical-stage biotechnology company, has established its European headquarters in the Netherlands. The company decided to invest in Holland to accelerate its growth within Europe’s biotechnology sector.
Rakuten Medical develops precision-targeted cancer therapies based on its proprietary photoimmunotherapy (PIT) platform. With its new European headquarters in Amsterdam, the company will also make additional hires across the globe to support its European growth.
